ArticleLeukemia2017

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells.

D T Saenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.